Comparison of mental health outcomes among adults with psoriasis on biologic versus oral therapies: a population-based study

References

• Kurd SK, Troxel AB, Crits-Christoph P, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:891–895.
   PubMed Web of Science ®Google Scholar
• Hayes J, Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther. 2010;23:174–180.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Schork NJ, Gupta AK, et al. Suicidal ideation in psoriasis. Int J Dermatol. 1993;32:188–190.
   PubMed Web of Science ®Google Scholar
• Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.
   PubMed Web of Science ®Google Scholar
• Pujol RM, Puig L, Daudén E, et al. Mental health self-assessment in patients with moderate to severe psoriasis: an observational, multicenter study of 1164 patients in Spain (the VACAP Study). Actas Dermosifiliogr. 2013;104:897–903.
   PubMedGoogle Scholar
• Dowlatshahi EA, Wakkee M, Arends LR, et al. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Invest Dermatol. 2014;134:1542–1551.
   PubMed Web of Science ®Google Scholar
• Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401–407.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959–976.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60:184–189.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–1292.
   PubMed Web of Science ®Google Scholar
• Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58:163–171.
   PubMed Web of Science ®Google Scholar
• Renzi C, Picardi A, Abeni D, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol. 2002;138:337–342.
   PubMed Web of Science ®Google Scholar
• Cohen JW, Cohen SB, Banthin JS. The medical expenditure panel survey: A national information resource to support healthcare cost research and inform policy and practice. Med Care. 2009;47:S44–S50.
   PubMed Web of Science ®Google Scholar
• Cohen SB, DiGaetano R, Goksel H. Methodology report #5: Estimation procedures in the 1996 MEPS Household Component [Internet]. Rockville (MD): Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality. 1999 May [cited 2018 Mar 15]. Available from: https://meps.ahrq.gov/data_files/publications/mr5/mr5.shtml
   Google Scholar
• Medical Expenditure Panel Survey: MEPS-HC Response Rates by Panel [Internet]. Rockville (MD): Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality. 2017 Aug 22 [cited 2018 Mar 15]. Available from: https://meps.ahrq.gov/survey_comp/hc_response_rate.jsp
   Google Scholar
• Robins LN, Regier DA. Psychiatric disorders in America: The epidemiologic catchment area study. New York (NY): The Free Press; 1990.
   Google Scholar
• Kessler RC, McGongle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19.
   PubMed Web of Science ®Google Scholar
• Meyer OL, Castro-Schilo L, Aguilar-Gaxiola S. Determinants of mental health and self-rated health: a model of socioeconomic status, neighborhood safety, and physical activity. Am J Public Health. 2014;104:1734–1741.
   PubMed Web of Science ®Google Scholar
• Tefft N. Mental Health and Employment: The SAD Story. Econ Hum Biol. 2012;10:242–255.
   PubMed Web of Science ®Google Scholar
• Lyketsos CG, Lopez O, Jones B, et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA. 2002;288:1475–1483.
   PubMed Web of Science ®Google Scholar
• Dreger S, Buck C, Bolte G. Material, psychosocial and sociodemographic determinants are associated with positive mental health in Europe: a cross-sectional study. BMJ Open. 2014;4:e005095.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Fleishman JA, Zuvekas SH. Global self-rated mental health: associations with other mental health measures and with role functioning. Med Care. 2007; 45:602–609.
   PubMed Web of Science ®Google Scholar
• Meyer N, Paul C, Feneron D, et al. Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol. 2010;24:1075–1082.
   PubMed Web of Science ®Google Scholar
• Schmid‐Ott G, Schallmayer S, Calliess IT. Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatization experience. Clin Dermatol. 2007;25:547–554.
   PubMed Web of Science ®Google Scholar
• Schmid‐Ott G, Künsebeck H‐W, Jäger B, et al. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol. 2005;85:27–32.
   PubMed Web of Science ®Google Scholar
• Vardy D, Besser A, Amir M, et al. Psychodermatology experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147:736–742.
   PubMed Web of Science ®Google Scholar
• Richards HL, Fortune DG, Griffiths CE, et al. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001; 50:11–15.
   PubMed Web of Science ®Google Scholar
• Young J. Cognitive therapy for personality disorders: a schema‐focused approach. Sarasota, FL: Professional Resource; 1994.
   Google Scholar
• Mizara A, Papadopoulos L, McBride SR. Core beliefs and psychological distress in patients with psoriasis and atopic dermatitis attending secondary care: the role of schemas in chronic skin disease. Br J Dermatol. 2012;166:986–993.
   PubMed Web of Science ®Google Scholar
• Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135:984–991.
   PubMed Web of Science ®Google Scholar
• Singh S, Taylor C, Kormehl H, et al. Psoriasis and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77:425–440.
   PubMed Web of Science ®Google Scholar
• Łakuta P, Przybyła-Basista H. Toward a better understanding of social anxiety and depression in psoriasis patients: The role of determinants, mediators, and moderators. J Psychosom Res. 2017;94:32–38.
   PubMed Web of Science ®Google Scholar
• Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007;21:901–912.
   PubMed Web of Science ®Google Scholar
• Gimeno D, Kivimaki M, Brunner EJ, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39:413–423.
   PubMed Web of Science ®Google Scholar
• Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006;367:29–35.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4:833–842.
   PubMed Web of Science ®Google Scholar
• Wohlrab J, Fiedler G, Gerdes S, et al. Recommendations for detection of individual risk for comorbidities in patients with psoriasis. Arch Dermatol Res. 2013;305:91–98.
   PubMed Web of Science ®Google Scholar